Papanicolaou Screening Behavior in Mothers and Human Papillomavirus Vaccine Uptake in Adolescent Girls
- 1 June 2009
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 99 (6) , 1137-1142
- https://doi.org/10.2105/ajph.2008.147876
Abstract
We investigated whether maternal attitude toward prevention, as indicated by history of seeking Papanicolaou (Pap) tests and contracting sexually transmitted infections, influenced human papillomavirus (HPV) vaccine uptake among their adolescent daughters. We linked the electronic health records of girls aged 9 to 17 years with their mothers at Kaiser Permanente Southern California (n = 148 350 mother-daughter pairs). Personal identifying information was removed from the data set after the matching of daughters and mothers was completed. We used logistic regression models to detect associations between mothers' history of Pap tests and abnormal results, genital or anal warts, and other sexually transmitted infections and daughters' HPV vaccine initiation and 3-dose regimen completion. Mothers' testing history was associated with daughters' likelihood for vaccination across ethnic and neighborhood socioeconomic strata (overall odds ratio [OR] = 1.47; 95% confidence interval [CI] = 1.43, 1.52). Mothers' history of sexually transmitted infections was only modestly associated with daughters' vaccination. Mothers' testing history was positively associated with daughters' regimen completion (overall OR = 1.42; 95% CI = 1.31, 1.54). Mothers' attitude toward prevention may influence HPV vaccine uptake among adolescent girls. The impacts of targeting mothers should be considered by HPV vaccination programs and investigated by further research.Keywords
This publication has 10 references indexed in Scilit:
- Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR. Recommendations and Reports, 2007
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- Factors That Are Associated With Parental Acceptance of Human Papillomavirus Vaccines: A Randomized Intervention Study of Written Information About HPVPublished by American Academy of Pediatrics (AAP) ,2006
- Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudesVaccine, 2006
- Predictors of STI vaccine acceptability among parents and their adolescent childrenJournal of Adolescent Health, 2005
- Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialThe Lancet Oncology, 2005
- Limitations and potential uses of census-based data on ethnicity in a diverse communityAnnals of Epidemiology, 2004
- Attitudes about human papillomavirus vaccine in young womenInternational Journal of STD & AIDS, 2003
- Screening for cervical cancer: recommendations and rationale.2003
- Informed Consent, Parental Permission, and Assent in Pediatric PracticePediatrics, 1995